WildBio
PrivateLast Round
Series A
Oct 16, 2025
Total Funding Raised
$85.71M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
WildBio is a biotechnology company that operates a cell biobank with a diverse array of African species cell lines, enabling the foodtech and biomedical sectors to create sustainable innovations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WildBio Comparables
Compare WildBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Livestock Laboratories & Biosciences | 78% | |
| Opo Bio | 78% | |
| Roslin Technologies | 77% |
WildBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 16, 2025 | ||||
| Grant | Jun 2, 2025 | ||||
| Grant | Jul 1, 2021 |
WildBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Braavos Investment Advisers | Seed, Series A |
| Oxford Science Enterprises | Seed, Series A |
| University of Oxford | Seed, Series A |
| Innovate UK | Grant |
| Advanced Research and Invention Agency | Grant |
| Ellison Institute of Technology | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 16, 2025
$60M round led by Ellison Institute of Technology
- Jun 2, 2025
$9.1M grant from Advanced Research and Invention Agency.
WildBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about WildBio's valuation, stock price, and market status.
Is WildBio a public or private company?
WildBio is a private company.
What is the current stock price of WildBio?
WildBio is a private company with no public stock price. No recent secondary market data is available.
How much is WildBio worth (valuation)?
Valuation information for WildBio is not publicly available.
Can I buy WildBio stock?
WildBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was WildBio's last funding round?
WildBio's most recent funding round was Series A on October 16, 2025.
Who are the main investors in WildBio?
Key investors in WildBio include Ellison Institute of Technology.
Will WildBio IPO soon?
No public IPO plans have been announced for WildBio.
How can I track WildBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor WildBio's secondary market activity and sign up for updates.